For example, CAV-1 was found to induce glycometabolic reprogramming in breast CAFs,51 while CAV-1-induced aerobic glycolysis was not completely verifiable in oral CAFs.52 Therefore, some alterations in CAFs appear only in cancers from one or a few tissue types, instead of a pan-cancer genome and transcriptome commonalities. This evidence concerns the gene CAV1 and cancer.